DC Field | Value | Language |
---|---|---|
dc.contributor.author | Mi Young Son | - |
dc.contributor.author | Jae Eun Kwak | - |
dc.contributor.author | Binna Seol | - |
dc.contributor.author | Da Yong Lee | - |
dc.contributor.author | Hyejin Jeon | - |
dc.contributor.author | Yee Sook Cho | - |
dc.date.accessioned | 2017-04-19T10:10:33Z | - |
dc.date.available | 2017-04-19T10:10:33Z | - |
dc.date.issued | 2015 | - |
dc.identifier.issn | 0022-3417 | - |
dc.identifier.uri | 10.1002/path.4551 | ko |
dc.identifier.uri | https://oak.kribb.re.kr/handle/201005/12799 | - |
dc.description.abstract | GM1 gangliosidosis (GM1) is an inherited neurodegenerative disorder caused by mutations in the lysosomal β-galactosidase (β-gal) gene. Insufficient β-gal activity leads to abnormal accumulation of GM1 gangliosides in tissues, particularly in the central nervous system, resulting in progressive neurodegeneration. Here, we report an in vitro human GM1 model, based on induced pluripotent stem cell (iPSC) technology. Neural progenitor cells differentiated from GM1 patient-derived iPSCs (GM1-NPCs) recapitulated the biochemical and molecular phenotypes of GM1, including defective β-gal activity and increased lysosomes. Importantly, the characterization of GM1-NPCs established that GM1 is significantly associated with the activation of inflammasomes, which play a critical role in the pathogenesis of various neurodegenerative diseases. Specific inflammasome inhibitors potently alleviated the disease-related phenotypes of GM1-NPCs in vitro and in vivo. Our data demonstrate that GM1-NPCs are a valuable in vitro human GM1 model and suggest that inflammasome activation is a novel target pathway for GM1 drug development. | - |
dc.publisher | Wiley | - |
dc.title | A novel human model of the neurodegenerative disease GM1 gangliosidosis using induced pluripotent stem cells demonstrates inflammasome activation | - |
dc.title.alternative | A novel human model of the neurodegenerative disease GM1 gangliosidosis using induced pluripotent stem cells demonstrates inflammasome activation | - |
dc.type | Article | - |
dc.citation.title | Journal of Pathology | - |
dc.citation.number | 1 | - |
dc.citation.endPage | 110 | - |
dc.citation.startPage | 98 | - |
dc.citation.volume | 237 | - |
dc.contributor.affiliatedAuthor | Mi Young Son | - |
dc.contributor.affiliatedAuthor | Jae Eun Kwak | - |
dc.contributor.affiliatedAuthor | Binna Seol | - |
dc.contributor.affiliatedAuthor | Da Yong Lee | - |
dc.contributor.affiliatedAuthor | Hyejin Jeon | - |
dc.contributor.affiliatedAuthor | Yee Sook Cho | - |
dc.contributor.alternativeName | 손미영 | - |
dc.contributor.alternativeName | 곽재은 | - |
dc.contributor.alternativeName | 설빛나 | - |
dc.contributor.alternativeName | 이다용 | - |
dc.contributor.alternativeName | 전혜진 | - |
dc.contributor.alternativeName | 조이숙 | - |
dc.identifier.bibliographicCitation | Journal of Pathology, vol. 237, no. 1, pp. 98-110 | - |
dc.identifier.doi | 10.1002/path.4551 | - |
dc.subject.keyword | GM1 gangliosidosis | - |
dc.subject.keyword | human disease model | - |
dc.subject.keyword | induced pluripotent stem cells | - |
dc.subject.keyword | inflammasome | - |
dc.subject.keyword | neural progenitor cells | - |
dc.subject.local | GM1 gangliosidosis | - |
dc.subject.local | human disease model | - |
dc.subject.local | Human disease model | - |
dc.subject.local | induced pluripotent stem cells | - |
dc.subject.local | inflammasome | - |
dc.subject.local | Inflammasome | - |
dc.subject.local | neural progenitor cells | - |
dc.description.journalClass | Y | - |
There are no files associated with this item.
Items in OpenAccess@KRIBB are protected by copyright, with all rights reserved, unless otherwise indicated.